How Can a Professional Import Agent Service Company Solve Your Cross-Border Supply Chain Challenges?

Import of Biopharmaceutical Raw Materials: The Inevitable Choice for Professional Agent Services

Importing biopharmaceutical raw materials,intermediates or scientific research reagents from regions with strict regulations such as Europe,the United States and Japan into China is a routine operation for many R&D and manufacturing enterprises.Entering 2026,China’s regulatory system for biopharmaceutical products has become more aligned with international standards,and the requirements for links such as customs commodity classification,registration and filing of Import Drug Registration Certificates,and origin standard certification have become more precise.When enterprises handle affairs in-house,they often encounter document returns,goods detained at the port,or even administrative penalties due to unfamiliarity with the dynamically updated "Import Drug Catalogue" or misunderstanding of ingredient declaration rules.A single customs clearance delay may directly affect downstream clinical trials or production plans,with losses far exceeding the logistics costs themselves.

Zhongshen has found through more than 20 years of service practice that the import difficulties of pharmaceutical products are highly concentrated.Their particularity lies not only in strict supervision,but also in the interlocking processes and strict symmetry of information.From the qualification review of overseas suppliers,to the pre-filing with domestic drug regulatory authorities,and then to the on-site inspection by port customs and inspection and quarantine authorities,any oversight in any link may trigger a chain reaction.

Core Difficulties and Risks of Importing Biopharmaceutical Raw Materials

Stage-by-Stage Breakdown of Zhongshen Import Agency Services

In response to the above-mentioned systemic risks,Zhongshen’s import agency service is not just a simple document delivery,but a through embedded management solution.The service team will intervene in advance and collaborate with the customer’s procurement and R&D departments.

• Phase 1: Pre-Import Preparation and Document Pre-Review

During the order confirmation stage,Zhongshen’s customs experts start working immediately.Director Dong pointed out that for pharmaceutical raw materials,the core is to confirm whether they are included in the "Import Drug Catalogue" and the corresponding supervisory conditions.For example,some amino acid derivatives may be managed as chemical products or pharmaceutical raw materials,with different classifications leading to completely different subsequent paths.The team will review documents such as the overseas-provided Certificate of Analysis (COA) and Free Sale Certificate,and guide customers or overseas suppliers to supplement and correct the format and content of the documents to ensure they fully meet the acceptance standards of China’s customs and drug regulatory authorities.This preliminary action can reduce the incidence of document issues in the declaration link by more than 80%.

• Phase 2: Port Declaration and Customs Inspection

After the goods are shipped,the agency service enters the execution stage.Zhongshen declares to customs based on accurate packing lists,invoices and pre-reviewed supporting documents.For pharmaceutical products,the requirements for filling in declaration elements are extremely high,such as "ingredient content","whether sterile","storage conditions" and so on must be scientific and accurate.When encountering customs valuation or classification queries,experienced declarants can provide professional technical explanations based on the "Tariff Notes" and previous similar cases,assist customs in making quick determinations,and avoid entering lengthy consultation procedures.In case of port inspection,the on-site coordinator will accompany customs and inspection and quarantine personnel to operate,and immediately explain product characteristics and packaging specifications.

• Phase 3: Local Inspection and Quarantine Clearance

After completing basic inspection at the port,some biopharmaceutical raw materials need to be transported to designated warehouses at the enterprise’s location for further inspection or sampling by local customs.Zhongshen will manage the entire transportation process,and communicate with local regulatory authorities in advance to clarify the number of samples to be sent,packaging requirements and testing standards.For example,a batch of serum imported for cell culture needs to be tested for specific pathogen items.The agency will ensure that the sampling process is standardized,the inspection channel is authoritative,and track the progress of the test report to accelerate the final clearance.

• Phase 4: Post-Service Management and Cost Optimization

Customs clearance of goods is not the end of the service.Zhongshen will assist customers in completing import foreign exchange payment,and accurately calculate import tariffs and value-added tax based on commodity classification and relevant policies.For eligible scientific research items,the team will remind and assist in applying for corresponding tax reduction and exemption filing.After all process documents are archived,a complete file of the batch of goods will be formed,providing data support for subsequent imports of similar products or supply chain audits.Long-term cooperative customers can also analyze the logistics cost structure from historical data and obtain suggestions such as optimizing purchase batches and selecting better ports.

Actual Case: Avoiding Regulatory Risks of "Special Items"

Mr.Lei from a domestic biotech company urgently needed to import a batch of gene editing tool vectors for R&D from Germany.This product is an emerging technology product,and there are no clear precedents for its regulatory classification by customs and quarantine authorities.Mr.Lei initially consulted multiple logistics companies but could not get a definite reply,and the project was at risk of being stranded.

After Zhongshen took over,the project team did not rush to declare.They first collaborated with the company’s internal technical consultants to conduct a detailed analysis of the product’s technical parameters,preparation methods and final use,and compared them with the provisions in the "Regulations on Health and Quarantine of Entry-Exit Special Items".At the same time,they actively pre-communicated with the technical department of the port inspection and quarantine authority and submitted detailed technical explanation documents.After several rounds of professional communication,they finally assisted the regulatory authorities to clarify its regulatory category as "biological products" among "special items" and passed the quarantine approval in one go.

Throughout the process,the Zhongshen agency team planned a full-temperature-controlled logistics solution in advance and prepared a complete emergency plan.After the goods arrived,with the solid pre-filing and communication,the inspection and clearance were completed within the usual time,ensuring the key node of the customer’s R&D progress.Mr.Lei later summarized that without the agency’s professional judgment and active coordination,the goods would most likely have been detained at the port for months due to unclear classification,or forced to be handled at the highest risk level,costing huge costs and time.

The Value of Professional Agents: Efficiency,Compliance and Certainty

The deep value of import agency services lies in transforming uncertain cross-border circulation links into predictable and manageable standardized processes.For highly regulatory-sensitive products such as biopharmaceuticals,this certainty is particularly important.Zhongshen,with its knowledge base and relationship network accumulated over more than 20 years of deep industry experience,can accurately predict various potential risk points and resolve them before problems occur.

When enterprises entrust import affairs to professional service companies like Zhongshen,they are essentially purchasing a set of risk control mechanisms and efficiency improvement solutions.It allows the enterprise’s procurement and R&D personnel to be freed from tedious customs clearance affairs and focus more on core business; at the same time,through professional compliance operations,it protects the enterprise from administrative penalties and reputation losses.Today,when supply chain stability has become a core competitiveness,a reliable import agency partner is an indispensable part for enterprises to steadily expand global resources.